The group that represents 5000 hospitals outlined a policy agenda that calls for regulatory reform but also seeks some certainty that patients who gained coverage under the Affordable Care Act will be able to retain it in the future.
The American Hospital Association (AHA) last week issued a pair of letters to President-elect Donald J. Trump, spelling out its policy agenda and calling on the new administration to lighten the regulatory load imposed in his predecessor’s final year.
But the AHA made clear that it wants to keep parts of President Barack Obama’s signature law—the Affordable Care Act—which has extended coverage to 20 million people and, in the process, bolstered the finances of many hospitals.
The first letter, dated November 30, 2016, outlined the AHA policy agenda, including regulatory reform, while the second, dated December 2, 2016, suggested 33 specific steps that the group said would “reduce the burdens on hospitals and the patients they serve.” Both letters were signed by AHA President and CEO Richard J. Pollack.
The second letter took particular aim at CMS’ final year of activity, which the hospital leaders say has produced 43 proposed and final rules “comprising almost 21,000 pages of text,” which the group claims “is beginning to outstrip the field’s ability to absorb them.”
AHA has previously expressed concern about how quickly CMS is pursuing new bundled payment models, as well as updating new reimbursement methods for things like hip and knee replacements while hospitals are still absorbing the initial wave of change.
Highlights of the AHA policy agenda are:
Besides the rules spelled out in its policy letter, the December 2, 2016, letter relists these and other rules that AHA would like to delay or suspend, including:
The AHA letter states that despite its flaws, the health reform law extended coverage to millions and withdrawing that coverage would return these Americans to the uncertainty seen before it passed. Hospitals, among other providers, are eager to know what r would replace the Medicaid dollars or tax subsidies that funded coverage for these patients.
“We urge to ensure that any repeal of portions of the ACA simultaneously include a replacement plan that continues to provide a mechanism for individuals to obtain affordable insurance coverage,” Pollack’s first letter stated.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More